HOME   |    PDF   |   


Title

Evaluating success rate of implants in patients with controlled Diabetes mellitus: A prospective comparative clinical study

 

Authors

Anjana Yogesh1,*, Pankaj Prakash2, Divya Vyas3, Amit Kumar4, J. Kumari Rathna5, N. Vatsala6 & Bhumika Kamal Badiyani4

 

Affiliation

1Department of Periodontics, KGF College of Dental Sciences, Kolar Gold Fields, Karnataka, India; 2Department of Dentistry, Dental Clinic, Air Force Station Darbhanga, Darbhanga, Bihar, India; 3Department of Pediatric and Preventive Dentistry, MM College of Dental Sciences and Research, Maharishi Markandeshwar, Mullana, Ambala, Haryana, India; 4Department of Public Health Dentistry, Mumbai, Maharashtra, India; 5Department of Oral and Maxillofacial Surgery, KGF College of Dental Sciences, Kolar Gold Fields, Karnataka, India; 6Department of Pediatric and Preventive Dentistry, KGF College of Dental Sciences, Kolar Gold Fields, Karnataka, India; *Corresponding author

 

Email

Anjana Yogesh - E-mail: anjuyogesh06@gmail.com
Pankaj Prakash - E-mail: pankajbhindwar@gmail.com
Divya Vyas - E-mail: divya.vyas@mmumullana.org
Amit Kumar - E-mail: dramitkumar05@gmail.com
J. Kumari Rathna - E-mail: drrathna2010@gmail.com
N. Vatsala – E-mail: drvatsbds@gmail.com
Bhumika Kamal Badiyani - E-mail: dr.bhumikab@gmail.com

 

Article Type

Research Article

 

Date

Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026

 

Abstract

Dental implant therapy in patients with diabetes remains clinically challenging because hyperglycemia can alter bone healing, osseointegration and peri-implant inflammatory responses even when systemic disease is considered controlled. This prospective comparative study evaluated 120 adults receiving a single posterior implant, including 60 participants with controlled type 2 diabetes mellitus (HbA1c 6.5-8.0%) and 60 metabolically healthy controls, with standardized placement and 12-month follow-up. At 12 months, implant survival was 98.3% in the controlled-diabetes group and 100% in controls, while strict implant success was 95.0% and 98.3%, respectively; the between-group differences were not statistically significant (p>0.05). Controlled-diabetes participants showed a modestly greater mean marginal bone loss (0.71 +/- 0.29 mm vs 0.56 +/- 0.24 mm, p=0.003) and slightly higher bleeding on probing, but implant stability remained high and no clinically important difference was detected in probing depth or suppuration. Thus, carefully selected patients with controlled type 2 diabetes achieved high implant survival and success, although closer peri-implant maintenance is justified because early crestal bone and inflammatory changes may be greater than in non-diabetic individuals.

 

Keywords

Dental implants, type 2 diabetes mellitus, HbA1c, implant survival, osseointegration, marginal bone loss

 

Citation

Yogesh et al. Bioinformation 22(10): 7317-7322 (2026)

 

Edited by

Ashwini Dhopte

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.